PRE TAX NTA |$3.62

Value as at close of business on 29 November 2024

Impact Video Series: Orygen

We interviewed leading individuals from our beneficiaries to discuss the importance of medical research, their recent breakthroughs and the vital need for private funding. 

In this video we talk to Professor Patrick McGorry AO, Executive Director at Orygen. Orygen has been nominated by Core Fund Manager, Cooper Investors.

     

    Recent Posts

    Read the latest insights
    A curated list of HM1 investor updates, portfolio news and other interesting articles.
    Read More
    ...